Article Details

CymaBay Therapeutics (NASDAQ:CBAY) Earns “Hold” Rating from HC Wainwright

Retrieved on: 2020-02-02 22:37:30

Tags for this article:

Click the tags to see associated articles and topics

CymaBay Therapeutics (NASDAQ:CBAY) Earns “Hold” Rating from HC Wainwright. View article details on hiswai:

Excerpt

<div>Finally, <b>Millennium Management</b> LLC raised its stake in shares of CymaBay Therapeutics by 401.5% in the third quarter. <b>Millennium Management</b> LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo